1. Home
  2. LGL vs XGN Comparison

LGL vs XGN Comparison

Compare LGL & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LGL Group Inc. (The)

LGL

LGL Group Inc. (The)

N/A

Current Price

$6.72

Market Cap

93.0M

Sector

Technology

ML Signal

N/A

Logo Exagen Inc.

XGN

Exagen Inc.

N/A

Current Price

$7.84

Market Cap

110.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LGL
XGN
Founded
1917
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
93.0M
110.7M
IPO Year
2017
2014

Fundamental Metrics

Financial Performance
Metric
LGL
XGN
Price
$6.72
$7.84
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$8.86
AVG Volume (30 Days)
15.0K
244.4K
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
37.50
N/A
EPS
N/A
N/A
Revenue
$4,169,000.00
N/A
Revenue This Year
N/A
$8.12
Revenue Next Year
N/A
$13.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.45
$2.59
52 Week High
$7.88
$12.23

Technical Indicators

Market Signals
Indicator
LGL
XGN
Relative Strength Index (RSI) 33.74 60.19
Support Level $6.65 $4.08
Resistance Level $7.37 $7.99
Average True Range (ATR) 0.27 0.40
MACD -0.10 -0.10
Stochastic Oscillator 5.26 58.29

Price Performance

Historical Comparison
LGL
XGN

About LGL LGL Group Inc. (The)

LGL Group Inc is a holding company engaged in services, merchant investment, and manufacturing business activities. The company has two reportable segments: Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications, including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.

About XGN Exagen Inc.

Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.

Share on Social Networks: